...
首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Visinin-like protein-1 overexpression is an indicator of lymph node metastasis and poor prognosis in colorectal cancer patients
【24h】

Visinin-like protein-1 overexpression is an indicator of lymph node metastasis and poor prognosis in colorectal cancer patients

机译:Visinin-like protein-1过表达是结直肠癌患者淋巴结转移和预后不良的指标

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Lymph node metastasis is an important factor determining outcome from colorectal cancer (CRC). Identification of molecular markers useful to predict lymph node metastasis is urgently needed. Our objective was to identify genes useful for characterization and prediction of lymph node metastasis in CRC. Gene expression profiles of cancer were determined by human U133 Plus 2.0 GeneChip? in 24 CRC patients, and patients with and without lymph node metastasis were compared. We focused on the visinin-like protein-1 (VSNL-1) gene and evaluated VSNL-1 mRNA expression levels with reverse transcriptase- polymerase chain reaction and immunohistochemical methods. Immunohistochemical evaluation of VSNL-1 mRNA expression was also performed in 143 other CRC patients to determine clinicopathological significance of VSNL-1. Twenty-four novel discriminating genes showed expression significantly different between patients with and without lymph node metastasis. Mean level of VSNL-1 mRNA expression in tumor tissue with lymph node metastasis was significantly higher than that in tissue without lymph node metastasis. Immunohistochemical examination demonstrated immunoreactivity for VSNL-1 in cytoplasm of the cancer cells with lymph node metastasis. High VSNL-1 expression was significantly associated with lymphatic invasion in stage II disease (p = 0.0061) and number of lymph node metastases in stage III disease (p = 0.0461). Patients with high VSNL-1 expression had significantly poorer prognosis than those with low expression in stage III disease (p = 0.045). This study is the first to demonstrate a prognostic role for VSNL-1 at the mRNA level, suggesting the possible usefulness of VSNL-1 as a predictor of lymph node metastasis and poor prognosis in CRC.
机译:淋巴结转移是决定结直肠癌(CRC)结局的重要因素。迫切需要鉴定可用于预测淋巴结转移的分子标记。我们的目标是鉴定可用于表征和预测CRC淋巴结转移的基因。癌症的基因表达谱由人U133 Plus 2.0 GeneChip?在24例CRC患者中,比较了有无淋巴结转移的患者。我们集中研究了类visinin蛋白-1(VSNL-1)基因,并通过逆转录聚合酶链反应和免疫组化方法评估了VSNL-1 mRNA的表达水平。还在143例其他CRC患者中进行了VSNL-1 mRNA表达的免疫组织化学评估,以确定VSNL-1的临床病理意义。 24种新的区分基因显示在有无淋巴结转移的患者之间表达明显不同。有淋巴结转移的肿瘤组织中VSNL-1 mRNA的平均表达水平显着高于无淋巴结转移的组织。免疫组织化学检查显示,VSNL-1在具有淋巴结转移的癌细胞的细胞质中具有免疫反应性。 VSNL-1的高表达与II期疾病的淋巴管浸润(p = 0.0061)和III期疾病的淋巴结转移数目(p = 0.0461)显着相关。 VSNL-1表达高的患者与III期疾病低表达的患者相比预后明显较差(p = 0.045)。这项研究是第一个在mRNA水平上证实VSNL-1的预后作用的研究,表明VSNL-1作为CRC淋巴结转移和预后不良的预测指标的可能有用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号